PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy
Crossref DOI link: https://doi.org/10.1186/s13148-016-0270-x
Published Online: 2016-09-26
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Holmes, Emily Eva
Goltz, Diane
Sailer, Verena
Jung, Maria
Meller, Sebastian
Uhl, Barbara
Dietrich, Jörn
Röhler, Magda
Ellinger, Jörg
Kristiansen, Glen
Dietrich, Dimo